229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.69%
Negative revenue growth while SONO stands at 32.73%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.69%
Gross profit growth under 50% of SONO's 31.79%. Michael Burry would be concerned about a severe competitive disadvantage.
10.00%
EBIT growth below 50% of SONO's 100.61%. Michael Burry would suspect deeper competitive or cost structure issues.
10.00%
Operating income growth under 50% of SONO's 95.22%. Michael Burry would be concerned about deeper cost or sales issues.
8.20%
Net income growth under 50% of SONO's 95.18%. Michael Burry would suspect the firm is falling well behind a key competitor.
9.68%
EPS growth under 50% of SONO's 94.83%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
13.33%
Diluted EPS growth under 50% of SONO's 94.83%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.59%
Share count expansion well above SONO's 0.42%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-2.25%
Reduced diluted shares while SONO is at 0.42%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
933.33%
OCF growth above 1.5x SONO's 162.75%. David Dodd would confirm a clear edge in underlying cash generation.
277.78%
FCF growth above 1.5x SONO's 150.11%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-32.46%
Negative 10Y revenue/share CAGR while SONO stands at 17.65%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-55.64%
Negative 5Y CAGR while SONO stands at 25.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-28.29%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
248.42%
10Y OCF/share CAGR at 75-90% of SONO's 292.53%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-52.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-34.48%
Negative 3Y OCF/share CAGR while SONO stands at 691.94%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-42.95%
Negative 10Y net income/share CAGR while SONO is at 82.31%. Joel Greenblatt sees a major red flag in long-term profit erosion.
87.45%
5Y net income/share CAGR similar to SONO's 94.61%. Walter Schloss might see both on parallel mid-term trajectories.
-52.09%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
55.74%
Equity/share CAGR of 55.74% while SONO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
35.24%
5Y equity/share CAGR is in line with SONO's 38.98%. Walter Schloss would see parallel mid-term profitability and retention policies.
83.71%
Positive short-term equity growth while SONO is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while SONO stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.07%
Firm’s AR is declining while SONO shows 133.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-42.11%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.82%
Negative asset growth while SONO invests at 5.33%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.01%
Under 50% of SONO's 3.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-4.92%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-4.63%
We cut SG&A while SONO invests at 2.76%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.
